Pfizer CEO: China to become a major competitor by 2030
PFE Pfizer Inc
$28.06 -1.44%
View chart & analysis → - 1Pfizer CEO Albert Bourla predicted that China will become a major competitor within five years.
- 2China has set a goal to develop 25% of the world's first-in-class drugs by 2030.
- 3Chinese companies have half the costs and are 3 to 4 times faster.
So what's the key point?
The head of Pfizer said China will become a strong competitor within five years. This is because Chinese companies have half the costs and are more than three times faster.
Source Pharmaceutical Technology +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.